FDA seeks public input on whether cannabis, CBD should be descheduled

420Patients.com is accepting qualified medical marijuana patients and caregivers to join our network. We value every registered member and we hope to serve you in Arizona. This article brought to you by 420 community friends mmjbusinessdaily.com

As the cannabis plant awaits a high-stakes review from international health authorities, the U.S. Food and Drug Administration (FDA) is asking the public to weigh in on whether cannabis, CBD and other cannabis extracts should be declassified as a controlled substance.

The United Nations’ World Health Organization (WHO) made a preliminary announcement in December that CBD has a low potential for abuse and shouldn’t be scheduled as a controlled substance.

FDA seeks public input on whether cannabis, CBD should be descheduled is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Leave a Reply

Skip to toolbar